Business Context and Reporting Period
This Form 8-K filing by Aptevo Therapeutics Inc. (APVO) reports on the results of the 2020 Annual Meeting of Stockholders held on May 27, 2020. The Company is incorporated in Delaware and its common stock trades on The Nasdaq Stock Market LLC.
Key Financial Metrics
This filing is a current report regarding corporate governance matters and does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The filing text does not provide a clear value for any financial metrics.
Material Changes Versus Prior Period
No material financial changes versus a prior comparable period are reported in this document, as it focuses exclusively on the outcomes of shareholder votes.
Guidance, Outlook, and Voting Results
The filing details the certified voting results for three proposals submitted to stockholders:
- Proposal 1 (Election of Directors): Stockholders elected two nominees to serve until the 2023 Annual Meeting.
- Zsolt Harsanyi, Ph.D.: 870,058 votes For; 414,039 votes Withheld.
- Barbara Lopez Kunz: 810,559 votes For; 473,538 votes Withheld.
- Proposal 2 (Stock Option Exchange Program): Stockholders approved the program.
- Results: 785,472 votes For; 491,986 votes Against; 6,639 Abstentions.
- Proposal 3 (Ratification of Auditors): Stockholders ratified the selection of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2020.
- Results: 2,519,668 votes For; 22,625 votes Against; 881 Abstentions.
The filing does not contain management commentary on future guidance, risks, contingencies, or unusual items.
Important Facts for Investor Verification
- Verify the final composition of the Board of Directors following the election of Zsolt Harsanyi and Barbara Lopez Kunz.
- Confirm the implementation details and terms of the approved stock option exchange program.
- Review the definitive proxy statement (Schedule 14A) filed on April 20, 2020, for detailed descriptions of the proposals and the context of the voting results.
- Note that this filing contains no financial performance data; refer to the most recent 10-K or 10-Q for financial metrics.